Netradyne, an industry-leading SaaS provider of artificial intelligence (AI) and edge computing, announced the close of a $90 million Series D round led by Point72 Private Investments with participation from Qualcomm Ventures and Pavilion Capital.
Grove announce $4.9 million seed round to revolutionize participant relationships in clinical trials. With the support of industry investors, led by A* with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels including Ajit Baid (former Head of Global Asset at UCB), Chloe Yoo (Director at ICON, former CFO at HumanFirst), Phuc Truong (former Co-Founder of CRIO), and Till Pieper (former Google Cloud AI lead), we are excited to make clinical trials more efficient, diverse, and participant-centric.
Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company announced the closing of a $207.5 million Series C financing. Proceeds will support the ongoing Phase 2b/3 and planned pivotal Phase 3 clinical trial for AVD-104 in geographic atrophy (GA), a vision-threatening condition secondary to advanced age-related macular degeneration, and the expansion into other ophthalmic indications.
Twentyeight Health, the leading digital-first women's healthcare platform delivering convenient, affordable, and stigma-free reproductive and sexual care in 43 states, announces $10 million in Series A funding led by Seae Ventures, with participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures.
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced the closing of a Series C funding round raising $105 million.
Tenvie Therapeutics launched with a commitment to transform the treatment of neurological diseases. The company combines a deep and diverse portfolio of small molecule assets, including programs acquired from Denali Therapeutics Inc., with a proven team of research and development leaders.
Plume announce a new $20M Series A funding round from both leading crypto & traditional financial institutions: Brevan Howard Digital, Lightspeed Faction, Haun Ventures, Galaxy Ventures, Hashkey, Laser Digital (Nomura Group), 280 Capital, Superscrypt, A Capital, SV Angel, Reciprocal Ventures, and others.
Borealis Biosciences, a next-generation RNA medicines company, today announced the appointment of Christian Hordo as CEO; a $30 million infusion from an extension of the Series A led by Westlake BioPartners; and the addition of three new board directors, David Allison, Ph.D., Tom Frohlich and Catherine Thut, Ph.D.
Fervo Energy, the leader in next-generation geothermal development, has secured $255 million in new funding and capital availability as it continues to build the world’s largest enhanced geothermal systems (“EGS”) power development. The announced funding comprises both opportunistic corporate equity and new debt financing.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.
